Clinical Trial Update: Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of BI 10773 in Type II Diabetes Patients With Different Degrees of Renal Impairment [Phase 1]

View source ↗

Summary

This Phase 1 study assessed the pharmacokinetics, pharmacodynamics, safety and tolerability of BI 10773 in adults with type 2 diabetes across different levels o…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• BI 10773

Snippet

Sponsor: Boehringer Ingelheim | Conditions: Diabetes Mellitus, Type 2 | Phase 1 | Status: COMPLETED | Results posted: 2014-07-14